Bologna IBD Markers
NCT02580864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2019-07-23
Summary
Individuate possible predictive factors of anti-TNFalfa-induced deep remission in Crohn's disease.
Conditions
Sponsors & Collaborators
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2018-10-31
- Completion
- 2019-01-31
Countries
- Italy
Study Locations
More Related Trials
-
Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
NCT06721767 ·Status: RECRUITING
-
Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases
NCT02179372 ·Status: COMPLETED ·Phase: NA
-
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study
NCT02364973 ·Status: COMPLETED
-
Long-term Outcome of TNF Alpha Therapy in IBD
NCT04575701 ·Status: COMPLETED
-
Endomicroscopy and Crohn´s Disease
NCT01102855 ·Status: COMPLETED
-
Predictors of Prognosis in IBD Patients
NCT05653011 ·Status: RECRUITING
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.
NCT06814392 ·Status: ACTIVE_NOT_RECRUITING
-
Progression of Damage in Ulcerative Colitis
NCT03955328 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
NCT03169894 ·Status: TERMINATED ·Phase: PHASE1
-
Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess
NCT02856763 ·Status: COMPLETED
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780 ·Status: COMPLETED
-
Biologics for Stricturing Crohn's Diseases
NCT05645055 ·Status: RECRUITING
-
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
NCT00587210 ·Status: COMPLETED
-
Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences
NCT02883296 ·Status: COMPLETED ·Phase: NA
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Multimodal Approach in IBD Patients
NCT01705522 ·Status: UNKNOWN
-
Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease
NCT06502873 ·Status: RECRUITING ·Phase: NA
-
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
NCT06551194 ·Status: RECRUITING
-
Magnetic Resonance Imaging of Motility in Crohn's 2
NCT03052465 ·Status: COMPLETED ·Phase: NA
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease
NCT03698500 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED